Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China flag China · Delayed Price · Currency is CNY
4.060
+0.040 (1.00%)
Feb 4, 2026, 3:00 PM CST

SHA:600594 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
593.7521.01699.47592.36379.63617.43
Short-Term Investments
-20---100.88
Cash & Short-Term Investments
593.7541.01699.47592.36379.63718.31
Cash Growth
-4.22%-22.66%18.08%56.04%-47.15%-32.60%
Accounts Receivable
378.55528.94692.32722.23698.66976.28
Other Receivables
30.838.8853.8456.4238.4242.48
Receivables
409.35567.82746.16778.65737.071,019
Inventory
545.5607.77586.65625.08554.63498.36
Other Current Assets
81.4733.4336.8744.5448.6548.75
Total Current Assets
1,6301,7502,0692,0411,7202,284
Property, Plant & Equipment
1,5231,6481,7551,8271,7091,419
Long-Term Investments
35.9936.4136.6637.4638.2741.16
Goodwill
131.26131.26164.04164.04777.66631.73
Other Intangible Assets
309.7319.56330.89362.03378.54341.97
Long-Term Deferred Tax Assets
100.790.3455.58229.96202.28191.32
Long-Term Deferred Charges
89.96103.47123.13145.72169.81172.7
Other Long-Term Assets
17.2320.5862.4263.1772.4144.16
Total Assets
3,8384,1004,5974,8705,0685,226
Accounts Payable
91.68117.98124.54133.25108.4784.72
Accrued Expenses
36.1257.7972.43103.6186.5786.39
Short-Term Debt
413.89380.93446.05537.11454.45745.55
Current Portion of Long-Term Debt
202.01227.68115.05162.15120.15345
Current Portion of Leases
-8.9813.9715.379.169.15
Current Income Taxes Payable
24.378.857.5421.0747.4241.98
Current Unearned Revenue
21.0127.1229.5267.5154.1523.05
Other Current Liabilities
79.34119.68120.49132.64199.01200.21
Total Current Liabilities
868.44949.01929.591,1731,0791,536
Long-Term Debt
229.56307.52387.22343.04315.9394.38
Long-Term Leases
20.6526.7830.3629.312.41-
Long-Term Unearned Revenue
90.7894.64106.31100.1867.641.38
Long-Term Deferred Tax Liabilities
33.2434.7437.4433.930.2625.69
Other Long-Term Liabilities
80.0680.988.070.65-65.75
Total Liabilities
1,3231,4941,5791,6801,5061,763
Common Stock
791.93791.93791.93791.93791.93791.93
Additional Paid-In Capital
653.84653.84653.84733.84766.15768.39
Retained Earnings
981.991,0691,4381,5181,9441,803
Treasury Stock
-25-25----
Comprehensive Income & Other
0.430.450.650.991.191.73
Total Common Equity
2,4032,4902,8843,0443,5033,365
Minority Interest
112.28116.35133.81145.8559.2597.96
Shareholders' Equity
2,5152,6063,0183,1903,5623,463
Total Liabilities & Equity
3,8384,1004,5974,8705,0685,226
Total Debt
866.11951.89992.651,087912.111,194
Net Cash (Debt)
-272.42-410.88-293.18-494.6-532.48-475.77
Net Cash Per Share
-0.35-0.52-0.37-0.62-0.67-0.60
Filing Date Shares Outstanding
784.39784.39791.93791.93791.93791.93
Total Common Shares Outstanding
784.39784.39791.93791.93791.93791.93
Working Capital
761.57801.011,140867.92640.59748.12
Book Value Per Share
3.063.173.643.844.424.25
Tangible Book Value
1,9622,0392,3902,5182,3472,391
Tangible Book Value Per Share
2.502.603.023.182.963.02
Buildings
-1,9111,8651,6861,3261,266
Machinery
-924.43933.15906.77809.92699.97
Construction In Progress
-0.74.99145.94472.4240.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.